Explore the groundbreaking development of novel anti-androgen therapies for castration-resistant prostate cancer, their mechanisms of action, and future research directions.
Explore the molecular mechanisms of androgen control in prostate cancer, from basic signaling to cutting-edge therapies targeting treatment resistance.
Exploring the promising results of a phase II trial combining docetaxel and degarelix for metastatic prostate cancer treatment.
Discover how the PDEF/Twist1 protein ratio distinguishes lethal prostate cancer from indolent disease, revolutionizing diagnosis and treatment.
Discover how precision tracking technology is revolutionizing prostate cancer radiation therapy, making treatments shorter and safer with real-time tumor tracking.
Exploring how ARAT agents are improving quality of life for men with metastatic castration-resistant prostate cancer
Understanding castration-resistant prostate cancer (CRPC), its molecular mechanisms, research breakthroughs, and revolutionary treatment approaches in precision medicine.
Exploring computational methods for predicting oxaliplatin efficacy in prostate cancer treatment through genetic analysis and in silico approaches.
Explore how aberrant Fer/STAT3 signaling drives prostate cancer progression to the androgen-refractory stage and emerging therapeutic strategies.
Exploring prostate cancer's metabolic adaptations and their role in therapy resistance through nuclear receptor pathways